Bioimpedance Spectroscopy involves the measurement of the impedance of biological tissues to assess various physiological parameters. It is widely utilized in medical diagnostics, particularly for ...

NEWARK, DE / ACCESSWIRE / July 6, 2023 / The Bioimpedance Spectroscopy Market is expected to grow at a significant rate in the coming years, driven by the rising number of obese population around the ...

Post-treatment surveillance with bioimpedance spectroscopy — which uses an electric current to measure intercellular fluid volume — reduced progression of breast cancer-related lymphedema requiring ...

The latest market research reveals an impressive trajectory of growth for the global bioimpedance spectroscopy market. Valued at USD 469.8 million in 2022, this burgeoning market is poised to soar to ...

Bioimpedance spectroscopy is an accurate non-invasive method for measuring body composition in adults, but in infants it requires further testing and validation. Of the few studies of bioimpedance ...

BRISBANE, Australia & CARLSBAD, Calif.--(BUSINESS WIRE)--Publication of a new study to assess the validity of L-Dex bioimpedance spectroscopy (BIS) measurements for evaluating the effectiveness of ...

Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman's risk for developing lymphedema after breast cancer surgery, according to interim results of a study led by Sheila ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Monitoring women ...

Safety and efficacy of alternating treatment with EP2006, a filgrastim biosimilar, and reference filgrastim for the prevention of severe neutropenia, in patients with breast cancer receiving ...

The Bioimpedance Spectroscopy Market was valued at US$ 469.8 million in 2022 and is anticipated to grow to US$ 1.4 billion by 2033. By 2023, sales are predicted to reach US$ 512.5 million. With a ...